I-Marijuana Yokwenziwa: Ingabe Isebenza?
Sibutsetelo
Isidakamizwa i-Cesamet (nabilone) iyinhlangano yesifo sangasese, okusho ukuthi kuyindlela yokwenza isinabisi (inambuzane). Ukusetshenziswa kwayo okuyinhloko kuphatha isicanucanu nokuhlanza kubantu abasebenzisa i-chemotherapy yomdlavuza.
Kodwa-ke, isetshenziselwa ukuphatha ubuhlungu obungapheli, kuhlanganise nobuhlungu be- fibromyalgia (i-FMS) . Akusiyo i-FDA evunyelwe kulokhu ukusetshenziswa, noma kunjalo.
I-Cesamet iyiHlelo II elilawulwayo ngenxa yengozi yokuhlukunyezwa.
Yilo lelo zinga elifanayo ne-Vicodin (i-hydrocodone acetaminophen).
Indlela Esebenza ngayo
I-Cesamet isebenza ngokubopha ezinye izitho zokwamukela ubuchopho (ezibizwa ngokuthi i-canabinoid receptors) nokushintsha izenzo zezinye amakhemikhali ebuchopho.
Kukholelwa ukuthi imiphumela yokwelashwa ivela kumakhemikhali ahlukene kunokubangela "ukuphakama" okuhlobene nokusetshenziswa kwensangu.
I-Cesamet ye-Fibromyalgia
Sinobufakazi obuningi bokuthi kuCesamet njengokwelashwa kwe-FMS. Iningi, kodwa hhayi yonke, lemiphumela lihle.
Ucwaningo olwenziwa ngo-2016 lwezinsana ze-cannabinoids zesifo se-rheumatic kuphetha ukuthi kwakungekho ubufakazi obanele bokuncoma lezi zidakamizwa.
Nokho, ezinye izifundo ziye zaba nemiphumela emihle. Ucwaningo lwe-2010 mayelana nokuthuthukiswa kokulala kwabantu abano-FMS nokuqwashisa bathola ukuthi i-Cesamet inempumelelo kakhulu kune- amitriptyline ejwayelekile yokucindezeleka.
Ukubuyekezwa kwezincwadi ngo-2016 ngokuphathwa kabuhlungu kwenzeka ukuthi i-Cesamet iboniswa ukuba nomphumela omncane kodwa ophawulekayo ebuhlungu obuvela ku-fibromyalgia, i- neuropathy , umdlavuza , nezinye izimo.
Ezimweni eziningi, abacwaningi bathola, basebenzisene nezinye izinhlungu zokwelashwa kunokuba kube nokwelapha okumele kube yedwa.
Kuzifundo zangaphambili nokubuyekezwa, imiphumela ebikiwe iye yahluka kusuka ezincane kuya ezibalulekile.
Ukuhlukunyezwa Okungenzeka
Ngokusho kocwaningo, ukuhlukunyezwa kwe-Cesamet kuyinqaba kakhulu. Noma kunjalo, kungenzeka, ikakhulukazi kubantu abanomlando wokuxhashaza isangu, utshwala, noma ezinye izidakamizwa, noma abanamalungu omndeni analo hlobo lomlando.
Qiniseka ukuthi uvumele udokotela wakho wazi uma usebenzisa imithi yakho eminingi kunalokho okushiwo. Angakusiza ukubhekana nanoma yiziphi izinkinga ezihilela ukuhlukunyezwa noma ukuxhomeka.
Isilinganiso
Ukuze ubuhlungu, i-Cesamet isilinganiso se-0.5 mg kabili ngosuku noma 1 mg kabili ngosuku. Ngokuvamile, isiguli siqala ngesilinganiso esincane futhi sanda kancane kancane.
Qiniseka ukuthi ulandela izincomo zesilinganiso somdokotela wakho eduze.
Okuqhamuka uma udla imishanguzo
Uma uhlangabezana nanoma yimuphi wale miphumela emibi kakhulu ngenkathi uthatha i-Cesamet, shayela udokotela wakho ngokushesha:
- ukushaya kwenhliziyo ngokushesha
- izindlu
- kunzima ukuqonda iqiniso
- ubunzima bokucabanga ngokucacile
Uma unemiphumela emibi elandelayo, futhi inzima noma ingahambi, kufanele uvumele udokotela wakho azi:
- ikhanda
- isiyezi
- indawo engazinzile
- ukulala
- izinkinga zokulala
- ubuthakathaka
- umlomo owomile
- izinguquko ekufuneni
- isiyaluyalu
- ukuzwakalisa noma ukuzwa sengathi 'uphakeme'
- ukukhathazeka ukugxila
- ukukhathazeka
- ukudideka
- ukucindezeleka
Esicwaningweni, abacwaningi babika ukuthi kwakungavamile ukuba abantu bahoxise ngenxa yemiphumela emibi.
Izimpawu zokudlula ngokweqile
Ukudlula ngaphezulu kunokwenzeka nge-Cesamet. Uma ubona izimpawu zokudlula ngokweqile, shayela ukulawulwa kobuthi ku-1-800-222-1222. Uma unomuntu oweqe noma engaphefumuli, shayela u-911 ngokushesha.
Izimpawu ze-overdose zifaka:
- ukushaya kwenhliziyo ngokushesha
- ugozi noma ikhanda elincane
- ukuphelelwa amandla
- izindlu
- ukukhathazeka
- ushintsho ekucabangeni kwakho, imizwelo yakho, noma ukuziphatha kwakho
- ukudideka
- ukuphefumula kancane
- i-coma
Ingabe Kukulungele?
Wena nodokotela wakho kufanele nixoxe nge-Cesamet uma ucabanga ukuthi yimithi ongathanda ukuyisebenzisa.
Qinisekisa ukuthi unesisindo sezinzuzo nezingozi, ubuyekeze izimpawu zakho zamanje kanye nemithi, futhi wenze isinqumo esinolwazi.
> Imithombo:
> I-Calandre EP, i-Rico-Villademoros F, i-Slim M. Umbono wezobuchwepheshe nge-pharmacotherapy. 2015 Jun; 16 (9): 1347-68. Isibuyekezo ku-pharmacotherapy yokwelapha i-fibromyalgia.
> Fitzcharles MA, et al. Schmerz. 2016 Feb; 30 (1): 47-61. Ukusebenza, > ukubekezelelana > nokuphepha kwama-cannabinoids ebuhlungu obungapheli obuhambisana nezifo ze-rheumatic (i-fibromyalgia syndrome, ubuhlungu bomhlane, i-osteoarthritis, i-rheumatoid arthritis): Ukubuyekezwa okuhlelekile kwezilingo ezilawulwa ngokungahleliwe.
> Sumpton JE, Moulin DE. I-Handbook ye-neurology emtholampilo. 2014; 119: 513-27. I-Fibromyalgia.
> Tsang CC, Giudice MG. Pharmacotherapy. 2016 Mar; 36 (3): 273-86. U-Nabilone we-Management of Pain.
> Ware MA, et al. I-anesthesia ne-analgesia. 2010 Feb 1; 110 (2): 604-10. Imiphumela ye-nabilone ekulele e-fibromyalgia: imiphumela yesilingo esilawulwa ngokungahleliwe.